Published in Q J Med on October 01, 1972
Variability of gluten intolerance in treated childhood coeliac disease. Gut (1979) 2.12
Intestinal permeability in coeliac disease: the response to gluten withdrawal and single-dose gluten challenge. Gut (1982) 1.65
Lack of harmful effect of oats on small-intestinal mucosa in coeliac disease. Br Med J (1974) 1.31
Slow and incomplete histological and functional recovery in adult gluten sensitive enteropathy. J Clin Pathol (1988) 0.94
Intestinal lactase, sucrase, and alkaline phosphatase in 373 patients with coeliac disease. J Clin Pathol (1984) 0.89
Delayed mouth-caecum transit of a lactulose labelled liquid test meal in patients with steatorrhoea caused by partially treated coeliac disease. Gut (1987) 0.84
Letter: Oats and coeliac disease. Br Med J (1974) 0.78
Diagnostic and Research Aspects of Small Intestinal Disaccharidases in Coeliac Disease. J Immunol Res (2017) 0.75
Measuring the response of the jejunal mucosa in adult coeliac disease to treatment with a gluten-free diet. Gut (1974) 0.75
An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet (1977) 7.89
A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin). Gut (1973) 6.09
The histological diagnosis of chronic gastritis in fibreoptic gastroscope biopsy specimens. J Clin Pathol (1972) 6.07
Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol (1998) 5.77
Haematemesis and melaena, with special reference to factors influencing the outcome. Br Med J (1970) 4.31
Long-term sequelae of Helicobacter pylori gastritis. Lancet (1995) 4.26
Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet (1974) 4.06
Quantitative histological studies on age changes in bone. J Pathol Bacteriol (1967) 3.69
Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut (1988) 3.66
Treatment of irritable bowel syndrome with lorazepam, hyoscine butylbromide, and ispaghula husk. Br Med J (1979) 3.56
Transit times of food in patients with diverticulosis or irritable colon syndrome and normal subjects. Br Med J (1967) 3.51
Prevalence of colonic diverticulosis in general population of Oxford area. Br Med J (1967) 3.44
Course and prognosis of Crohn's disease. Gut (1976) 3.02
A method for the quantitation of small intestinal biopsy specimens. J Clin Pathol (1972) 2.96
Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis. Gut (1980) 2.81
Gastric ulcer and gastritis. Gut (1971) 2.58
Gastric cancer simulating benign gastric ulcer. Br J Surg (1969) 2.27
Auto-immune reactions in ulcerative colitis. Gut (1966) 2.26
Further experience in the treatment of severe attacks of ulcerative colitis. Lancet (1978) 2.25
Azathioprine in ulcerative colitis: final report on controlled therapeutic trial. Br Med J (1974) 2.24
The plasma cells in inflammatory disease of the colon: a quantitative study. J Clin Pathol (1974) 2.13
Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety. Am J Gastroenterol (1995) 2.12
Method of preparing isolated colonic epithelial cells (colonocytes) for metabolic studies. Gut (1979) 2.08
Ischaemic enterocolitis: an expression of the intravascular coagulation syndrome. Gut (1971) 1.98
Jejunal mucosal recovery in coeliac disease in relation to the degree of adherence to a gluten-free diet. Q J Med (1974) 1.95
Long term serological surveillance after treatment of Helicobacter pylori infection. Gut (1991) 1.90
Ulcerative colitis and pregnancy. Gut (1980) 1.90
The histological classification of duodenitis in fibreoptic biopsy specimens. Digestion (1975) 1.89
Definition of polymorphisms and haplotypes in the interleukin-12B gene: association with IL-12 production but not with Crohn's disease. Genes Immun (2004) 1.89
Seroconversion for Helicobacter pylori. Lancet (1993) 1.88
Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol (1996) 1.86
HLA-DW3 associated with coeliac disease. Lancet (1976) 1.79
Crohn's disease and carcinoma of colon. Br Med J (1968) 1.77
Abnormalities in the apparently normal bowel mucosa in Crohn's disease. Lancet (1976) 1.77
An immunoperoxidase technique for the identification of gastrin-producing cells. J Clin Pathol (1974) 1.71
Effect of transport medium and transportation time on culture of Helicobacter pylori from gastric biopsy specimens. J Clin Pathol (1993) 1.66
HLA-DR phenotypes in Spanish coeliac children: their contribution to the understanding of the genetics of the disease. Gut (1983) 1.65
IL1B gene polymorphisms influence the course and severity of inflammatory bowel disease. Immunogenetics (1999) 1.62
Distribution and metabolism in healthy volunteers of disodium azodisalicylate, a potential therapeutic agent for ulcerative colitis. Gut (1982) 1.60
Genetic basis of gluten-sentitive enteropathy. Gastroenterology (1978) 1.60
Interleukin-1 receptor antagonist gene polymorphism and multiple sclerosis. Lancet (1995) 1.53
Gastroscopy with biopsy and cytological sampling under direct vision. Br Med J (1968) 1.53
Accuracy and cost-effectiveness of a new strategy to screen for celiac disease in children with Down syndrome. J Pediatr (2000) 1.53
Effect of oral zinc supplementation on metallothionein and superoxide dismutase concentrations in patients with inflammatory bowel disease. J Gastroenterol Hepatol (1995) 1.52
Evidence of genetic heterogeneity in IBD: 1. The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis. Eur J Gastroenterol Hepatol (1996) 1.52
Measuring intraepithelial lymphocytes, surface area, and volume of lamina propria in the jejunal mucosa of coeliac patients. Gut (1979) 1.48
Current methods to diagnose the unresponsive and complicated forms of coeliac disease. Eur J Intern Med (2010) 1.47
The effect of topical N-acetyl-5-aminosalicylic acid in ulcerative colitis. Scand J Gastroenterol (1980) 1.46
Association of NOD2/CARD15 mutations with previous surgical procedures in Crohn's disease. Rev Esp Enferm Dig (2005) 1.44
TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol (1997) 1.43
Hypolactasia and the irritable colon syndrome. Scand J Gastroenterol (1972) 1.42
Comparison of disodium cromoglycate and sulphasalazine as maintenance therapy for ulcerative colitis. Lancet (1979) 1.40
Seroreactivity of patients with Crohn's disease with lymph nodes of primed nude mice is independent of the tissue used for priming. Gastroenterology (1989) 1.40
The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man. Br J Clin Pharmacol (1982) 1.40
Immunosuppression in the treatment of inflammatory bowel disease. I. Changes in lymphoid sub-populations in the blood and rectal mucosa following cessation of treatment with azathioprine. Clin Exp Immunol (1974) 1.39
[Optimizing treatment of complicated forms of inflammatory bowel disease. Fistulizing Crohn's disease]. An Med Interna (2003) 1.39
Allelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clin Exp Immunol (1995) 1.39
Crohn's disease of the mouth and lips. Gut (1971) 1.39
15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells. Cancer Res (2001) 1.37
Familial incidence of Crohn's disease in The Netherlands and a review of the literature. Gastroenterology (1984) 1.36
Presence of Helicobacter pylori in the oral cavity, oesophagus, stomach and faeces of patients with gastritis. Eur J Clin Microbiol Infect Dis (1995) 1.35
Mitosis counting--a need for reappraisal. Hum Pathol (1981) 1.35
A TaqI polymorphism in the 3'UTR of the IL-12 p40 gene correlates with increased IL-12 secretion. Genes Immun (2002) 1.33
Morphological methods in the study of the gut immune system in man. J Clin Pathol (1976) 1.33
Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD). Clin Exp Immunol (1996) 1.33
Importance of the fiberoptic endoscope cleaning procedure for detection of Helicobacter pylori in gastric biopsy specimens by PCR. J Clin Microbiol (1994) 1.32
The Paneth cell. Gut (1979) 1.32
Circulating and tissue eosinophils in ulcerative colitis. Am J Dig Dis (1966) 1.32
Lack of harmful effect of oats on small-intestinal mucosa in coeliac disease. Br Med J (1974) 1.31
Stimulation of lymphocytes from patients with coeliac disease by a subfraction of gluten. Lancet (1976) 1.31
Propulsion and retropulsion of normal colonic contents. Am J Dig Dis (1971) 1.30
The timing of histological damage following a single challenge with gluten in treated coeliac disease. Q J Med (1981) 1.29
Azathioprine in ulcerative colitis: an interim report on a controlled therapeutic trial. Br Med J (1972) 1.28
ELISA assay for quantitative measurement of human immunoglobulins IgA, IgG, and IgM in nanograms. J Immunol Methods (1983) 1.28
The liver in ulcerative colitis. Q J Med (1971) 1.27
Glucosamine synthetase activity of the colonic mucosa in ulcerative colitis and Crohn's disease. Gut (1977) 1.26
Gastritis duodenitis, and circulating levels of gastrin in duodenal ulcer before and after vagotomy. Gut (1976) 1.25
Cerebral venous thrombosis as a complication of ulcerative colitis. Am J Dig Dis (1967) 1.25
Ultrastructure within the lateral plexus of the Limulus eye. J Gen Physiol (1972) 1.25
Epidemiology of proctocolitis in the region of Leiden, The Netherlands. A population study from 1979 to 1983. Scand J Gastroenterol (1987) 1.23
Comparison of various treatments for irritable bowel syndrome. Br Med J (1980) 1.20
The role of various cereals in coeliac disease. Q J Med (1978) 1.19
Epidemiology of Crohn's disease in Regio Leiden, The Netherlands. A population study from 1979 to 1983. Gastroenterology (1987) 1.17
The liver in Crohn's disease. Q J Med (1971) 1.16
Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST). Ann Oncol (2008) 1.16
Influence of age and Helicobacter pylori infection on serum pepsinogens in healthy blood transfusion donors. Gut (1992) 1.16
Circulating antibodies to cow's milk proteins in ulcerative colitis. Gut (1972) 1.16
The long-term prognosis of ileorectal anastomosis and proctocolectomy in Crohn's disease. Scand J Gastroenterol (1976) 1.16
Age and sex variations in the fat of the adrenal cortex of the white rat. J Anat (1942) 1.15
Identifying toxic fractions of wheat gluten and their effect on the jejunal mucosa in coeliac disease. Gut (1974) 1.13
Proctocolectomy for ulcerative colitis. World J Surg (1980) 1.12